Ryan Moorman, P.C.

Commercial Cases

• Pharmaceutical Arbitration: Lead trial counsel for major pharmaceutical company in dispute with a contract manufacturing customer. Three member panel ruled in favor of client on all its claims and awarded its full damages request plus attorneys’ fees.
  
• Crop Protection Arbitration: Trial counsel for major agrichemical company in contract dispute with former collaboration partner. Won confidential award as plaintiff against former collaboration partner in R&D joint venture.
  
• Incyte Corp. v. Flexus Biosciences: Trial counsel for Flexus Biosciences, now a Bristol-Myers Squibb subsidiary, in a billion-dollar trade secrets misappropriation case. At the conclusion of a twelve-day trial, after the court eliminated several claims at summary judgment, the jury returned a unanimous defense verdict on all the remaining counts.
  
• RCT Corporation v. Eli Lilly and Company: Hired as counsel for Eli Lilly and Company after previous counsel lost key motion in dispute seeking royalties on insulin sales allegedly owed under license agreement.
  
• Nektar Therapeutics v. Eli Lilly and Company: Counsel for Eli Lilly and Company in commercial dispute with former collaboration partner. Secured dismissal of multiple claims at the pleading stage.
  
• Plastic Reclamation Partners v. MRC Polymers: Hired as counsel for plaintiff Plastic Reclamation Partners after close of fact discovery in dispute alleging sellers committed fraud in sale of plastic recycling technology.
  
• Realogy v. SIRVA: Counsel for SIRVA, a Madison Dearborn Partners portfolio company, in securing dismissal of claims seeking to force closing of $400 million merger.
  
• Abbott Laboratories v. Alere, Inc.: Counsel for Abbott Laboratories in its merger dispute with Alere, Inc., which Abbott was to acquire for $8.4 billion. Litigation strategy helped Abbott secure an approximately $500 million purchase price reduction.

False Claims Act Cases

• Proctor v. Safeway; Schutte v. SuperValu: Trial and litigation counsel for Albertsons Companies’ affiliates in FCA suit challenging Medicare and Medicaid submissions over nine-year period. Secured summary judgment in both cases within year after taking over for prior counsel. Judgments affirmed on appeal.
  
• Elliott-Lewis v. Abbott Laboratories: Secured dismissal of FCA claims for Abbott Laboratories in FCA cases in Massachusetts. Secured summary judgment of remaining retaliation claims.
  
• Berkley v. New Harbor Capital: Counsel for New Harbor Capital and portfolio companies in FCA case brought in Rhode Island.
  
• Streck v. Eli Lilly and Company: Trial counsel for Eli Lilly and Company in FCA case related to Medicaid reimbursement.

Intellectual Property Cases

• Pharmaceutical Arbitration: Trial counsel for major pharmaceutical company in arbitration seeking to invalidate nine-figure royalty stream in license agreement. Achieved complete defense victory after one-week arbitration.
  
• PDL BioPharma v. Eli Lilly and Company: Counsel for Eli Lilly and Company in suit related to the humanization and development of Lilly’s Alzheimer’s treatment.
  
• FMC Corporation v. Syngenta: Argued and won motion to compel arbitration for Syngenta in suit seeking to correct inventorship on multiple patents.